Pfizer (PFE) Other Operating Expenses (2010 - 2017)

Pfizer (PFE) has 8 years of Other Operating Expenses data on file, last reported at -$6.7 billion in Q4 2017.

• Quarterly Other Operating Expenses rose 12.65% year-over-year to -$6.7 billion in Q4 2017, while the trailing twelve-month figure through Sep 2018 was -$6.7 billion (up 71.67% YoY) and the FY2017 annual result came in at -$22.7 billion, up 6.78% from the prior year.
• Other Operating Expenses declined to -$6.7 billion in Q4 2017 per PFE's latest filing, from -$5.4 billion in the prior quarter.
• Across five years, Other Operating Expenses topped out at $1.1 billion in Q2 2013 and bottomed at -$7.9 billion in Q4 2015.
• The 5-year median for Other Operating Expenses is -$5.3 billion (2017), against an average of -$3.9 billion.
• The widest annual swing landed in 2013, when Other Operating Expenses jumped 255.52%; it then tumbled 9796.23% in 2015.
• Tracing PFE's Other Operating Expenses over 5 years: stood at $18.0 million in 2013, then surged by 194.44% to $53.0 million in 2014, then sank by 14983.02% to -$7.9 billion in 2015, then climbed by 2.69% to -$7.7 billion in 2016, then climbed by 12.65% to -$6.7 billion in 2017.
• Per Business Quant, the three latest PFE Other Operating Expenses figures stand at -$6.7 billion (Q4 2017), -$5.4 billion (Q4 2017), and -$5.3 billion (Q3 2017).

Peer Comparison